Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?

D Jonigk, C Werlein, T Acker, M Aepfelbacher… - Virchows Archiv, 2022 - Springer
The use of autopsies in medicine has been declining. The COVID-19 pandemic has
documented and rejuvenated the importance of autopsies as a tool of modern medicine. In …

Post-COVID-19 cholangiopathy: a systematic review

B Yanny, M Alkhero, M Alani, D Stenberg… - Journal of Clinical and …, 2023 - Elsevier
Objectives Post-COVID-19 cholangiopathy (PCC) is a rare but poorly understood and
serious complication of COVID-19 infection. We sought to better understand the …

Long COVID-19 liver manifestation in children

S Cooper, A Tobar, O Konen, N Orenstein… - Journal of pediatric …, 2022 - journals.lww.com
Objectives: Severe acute respiratory syndrome coronavirus 2, the novel coronavirus
responsible for coronavirus disease (COVID-19), has been a major cause of morbidity and …

Liver transplantation for post-COVID-19 sclerosing cholangitis

A Lee, AN Wein, MBM Doyle… - BMJ Case Reports …, 2021 - casereports.bmj.com
Since identified in December 2019, COVID-19 has remained a pandemic across the globe.
Although primarily a respiratory illness, the impact of COVID-19 on other end organs has …

Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients

S Leonhardt, C Jürgensen, J Frohme, D Grajecki… - Hepatology …, 2023 - Springer
Background Increasing evidence suggests that secondary sclerosing cholangitis (SSC),
which can lead to cirrhosis or liver failure, may be a hepatobiliary long-term complication of …

COVID‐19‐associated cholangiopathy: What is left after the virus has gone?

N Heucke, V Keitel - Hepatology, 2022 - journals.lww.com
Hepatic interferon regulatory factor 8 expression suppresses... : Hepatology Hepatic interferon
regulatory factor 8 expression suppresses hepatocellular carcinoma progression and enhances …

Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis–A review of cholangiographic and ultrasound imaging

K Möller, B Braden, EL Culver, C Jenssen… - Endoscopic …, 2023 - journals.lww.com
Sclerosing cholangitis (SC) represents a spectrum of chronic progressive cholestatic
diseases of the intrahepatic and/or extrahepatic biliary system characterized by patchy …

[HTML][HTML] Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies

A Bartoli, C Cursaro, P Andreone - Current Opinion in …, 2022 - journals.lww.com
Two different cholangiopathies have been reported in patients after severe-COVID-19.
Attention should be paid to the development of cholestasis in ICU setting but above all after …

Post-COVID cholangiopathy: A narrative review

J Caballero-Alvarado, CZ Corvera, BM Bacilio… - Gastroenterologia y …, 2023 - Elsevier
Since the spread of the first cases of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection much progress has been made in understanding the disease …

Secondary sclerosing cholangitis after SARS-CoV2: ICU ketamine use or virus-specific biliary tropism and injury in the context of biliary ischemia in critically ill patients …

A Bartoli, C Cursaro, H Seferi… - … Medicine: Evidence and …, 2023 - Taylor & Francis
Purpose From the beginning of the Severe Acute Respiratory Syndrome CoronaVirus-2
(SARS-CoV2) pandemic, different cases of a cholangiopathy with features of secondary …